How do I order a urine albumin‑to‑creatinine ratio (UACR) for an adult being screened or monitored for kidney disease such as diabetes, hypertension, or chronic kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Order a Urine Albumin-to-Creatinine Ratio (UACR)

Specimen Collection Method

Order a first-morning void spot urine sample for UACR measurement—this is the preferred collection method because it provides the lowest coefficient of variation (31%) and best reproducibility compared to random samples or 24-hour collections. 1

  • If a first-morning void is not practical (e.g., in outpatient clinic settings), a random spot urine sample is acceptable, though it will have slightly higher variability. 1, 2
  • Never order a 24-hour urine collection—spot UACR is more convenient, equally accurate, and eliminates the errors inherent in timed collections. 1

Specific Ordering Instructions

  • Order as: "Urine albumin-to-creatinine ratio" or "UACR" on a spot (untimed) urine sample 1
  • The laboratory will measure both urinary albumin (mg/L) and urinary creatinine (mg/dL or g/L) from the same sample and report the ratio in mg/g 1
  • Ensure the laboratory's lower limit of quantitation for albumin is ≤3 mg/L to maximize diagnostic utility, particularly for detecting low-level albuminuria with prognostic significance 3

Timing and Patient Preparation

  • Collect at the same time of day for serial monitoring to minimize variability 1
  • The patient should not have eaten for at least 2 hours prior to collection 1
  • Avoid collection during or within 24 hours of:
    • Vigorous exercise 1
    • Active urinary tract infection or fever 1
    • Menstruation 1
    • Congestive heart failure exacerbation 1
    • Marked hyperglycemia 1
    • Uncontrolled hypertension 1

Confirmation Strategy

Because UACR has high day-to-day variability (coefficient of variation ~49%), you must confirm any elevated result (≥30 mg/g) with 2 additional first-morning samples over the subsequent 3–6 months before diagnosing persistent albuminuria. 1, 4

  • If 2 out of 3 samples show ACR ≥30 mg/g, the diagnosis of persistent albuminuria is confirmed 1
  • A single elevated UACR has only a 50% probability of representing a true ≥30% change; obtaining 2 collections at each time point increases this probability to 97% 4

Screening Frequency by Population

Patient Population When to Begin Screening Frequency
Type 1 diabetes 5 years after diagnosis [1] Annually [1]
Type 2 diabetes At time of diagnosis [1] Annually [1]
Hypertension or other CKD risk factors At diagnosis [2] Every 1–2 years [2]
eGFR <60 mL/min/1.73 m² or ACR ≥30 mg/g Already established Every 6 months [1]

Result Interpretation Categories

  • Normal: <30 mg/g creatinine 1
  • Moderately increased albuminuria (A2): 30–299 mg/g creatinine 1
  • Severely increased albuminuria (A3): ≥300 mg/g creatinine 1

Common Pitfalls to Avoid

  • Do not order "urine protein" or "urine dipstick protein" instead of UACR for diabetic patients—albumin is the preferred and more sensitive marker 5
  • Do not rely on urine albumin alone without simultaneous creatinine measurement, as this is susceptible to false results from variations in urine concentration 1
  • Do not assume a single normal UACR excludes future risk—UACR is a continuous variable, and even values within the normal range (<30 mg/g) carry prognostic information for cardiovascular and renal outcomes 1
  • Do not forget to order serum creatinine and calculate eGFR simultaneously—30–50% of diabetic CKD cases present with reduced eGFR without albuminuria 6

References

Guideline

Use of Creatinine in Albumin-to-Creatinine Ratio for Kidney Damage Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024

Guideline

Understanding and Managing Elevated Urine Spot Creatinine Protein Ratio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Urine Creatinine with Normal Urine Albumin-to-Creatinine Ratio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.